drug screening
HHS OIG Report Finds Drug Testing Overpayments Cost CMS $216M
The agency's audit analyzed $3 billion in Medicare payments over five years for definitive drug testing services for 22 or more drug classes.
GBS Inks Deal to Acquire Drug Screening Firm Intelligent Fingerprinting
Under the terms of the deal, GBS has until the end of the year to evaluate and negotiate the acquisition of IFP and its assets.
Ortho Clinical Diagnostics, Hangzhou AllTest Biotech, Others Obtain FDA Clearances in January
Ortho got the green light for a reagent pack used to measure creatine kinase myocardial band on the firm's Vitros 3600 Immunodiagnostic System.
Joint Venture From SEngine, Gustave Roussy Aims to Commercialize Cancer Dx Test Across Europe
Premium
SEngine's PARIS test combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis.
MD Labs to Pay up to $16M to Resolve Allegations of False Claims for Urine Drug Testing
The US DOJ said MD Labs and its cofounders admitted that between 2015 and 2019, they regularly billed federal healthcare programs for medically unnecessary urine drug testing.